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T HE CONTINUOUS measurement of mixed venous oxygen saturation (SVO,) by means of an Oximetrix pulmonary artery catheter (Abbott Critical Care Systems, North Chicago, IL) has been claimed to be an early, accurate, instantaneous, and cost-effective indicator of hemodynamic changes in critically ill patients.lW3 Differing opinions have been expressed regarding both the cost-effectiveness and usefulness of these catheters for the measurement of SS02 in various classes of patients.'s3 Cost-containment pressures exerted upon hospitals and their medical staffs have been increasing for several years. Despite these pressures, costs continue to rise due to inflation, as well as to the introduction of new technologies such as the Oximetrix pulmonary artery catheter.
have been routinely placed preoperatively in all patients undergoing elective coronary artery bypass grafting.
The cost of the Oximetrix pulmonary artery catheter purchased at the authors' institution is approximately four times that of a conventional pulmonary artery catheter. Since August 1985, Oximetrix pulmonary artery catheters
The purpose of this retrospective study was to determine the cost-effectiveness and possible alterations in postoperative care of coronary artery bypass graft patients following the introduction of pulmonary artery catheters with continuous measurement of SVO,. The cost-effectiveness of these catheters was evaluated by searching for a decrease in the various lengthof-stay parameters measured, or for a decrease in the number of postoperative days of mechanical ventilation or postoperative cardiac outputs performed in the group in which SVO, was monitored. The effects of continuous SV02 monitoring on hospital morbidity were evaluated by analysis of the length of the various postoperative stay parameters. Rates of mortality were also examined in these groups of patients during comparable periods before and after Oximetrix catheters were routinely used.
The charts of 41 patients undergoing coronary artery bypass grafting by a single surgeon during the months of March and April, 1985 (group l), and the charts of 46 patients undergoing the same procedure by the same surgeon during the same months in 1987 (group 2) were reviewed retrospectively.
A retrospective methodology was the necessary mode of evaluation of the cost-effectiveness of this particular technological advance for two reasons. First, a restrospective audit ensured that no bias could be introduced into the study by knowledge on the part of physicians and other care providers that a study (particularly one that examined treatment and treatment decision-making) was
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MEASUREMENT 277 Postoperative intensive care days 6.8 f 1.9 5.6 + 0.7 0.42 being conducted. Second, the surgeon involved felt so strongly that this monitoring technique was valuable that he opposed a randomized prospective study that would allocate patients into a group that would be denied, by any method, this form of monitoring.
The months of March and April of each year were chosen for study to assure that the house staff caring for these patients in the thoracic intensive care unit (ICU) would have a relatively high level of training and would not be new to either the institution or their training program. The same period in each year was chosen to assure that similar levels of training existed in the surgical house staff caring for the patients being studied. Patients operated upon by a single surgeon were chosen to eliminate the possibility that attitudes of the surgeon in charge might bias results. No protocol existed in the ICU governing the response to changes in measured SvOo,. Decisions regarding these responses were solely at the discretion of the house officer on duty in the unit.
Variables were chosen for analysis in an attempt to highlight cost savings in the second group of patients, which might have been the result of monitoring of Sv02 through the use of Oximetrix pulmonary artery catheters. The relative acuity of the two groups of patients and the differences in morbidity and mortality between these groups were also noted. Values for the following variables were determined for each patient: (I) total days of hospitalization, (2) total days of preoperative hospitalization, (3) total days of postoperative hospitalization, (4) number of preoperative arterial blood gas (ABC) determinations, (5) number of postoperative ABC determinations, (6) number of days of postoperative mechanical ventilation, (7) number of preoperative days spent in the ICU, (8) number of cardiac output determinations performed postoperatively, and (9) number of postoperative days spent in the ICU. Additionally, morbidity and mortality during the hospitalization were recorded for each group. The mean value *SD for each variable was determined for each group. Comparisons between groups were then made for each variable using the Student's t-test. Differences between the two groups were considered significant if P C 0.05. Table 1 demonstrate no statistically significant difference between the two groups in the total number of hospital days, total number of postoperative hospital days, total number of preoperative ABG determinations, total number of postoperative ABG determinations, total number of days of postoperative mechanical ventilation, and total number of postoperative days spent in the ICU. In addition, no difference in the in-hospital morbidity or mortality rate was noted.
RESULTS

Data presented in
Group 1 had significantly longer preoperative hospitalizations (P < 0.01) and. a greater number of preoperative days spent in the ICU (P < 0.007). Group 2 had a greater number of postoperative cardiac output determinations (P < 0.02). Table 2 presents variables in which statistical noted.
the data for the significance was DISCUSSION Hospitals, doctors, and the health care industry in general are presently caught in an ever more stringent cost-containment environment. As a result, technological advances in medical care can no longer be accepted for general use without convincing evidence of their cost-effectiveness, as well as their efficacy and safety. Cost-containment pressures are increasing from the federal sector as well as from private third-party payers. The proliferation of health maintenance organizations, preferred provider organizations, and other prepaid medical plans The lack of difference between the two groups regarding the variables displayed in Table 1 indicates that the overall level of acuity for the two groups of patients was comparable. The significantly longer preoperative hospitalizations and longer preoperative ICU stays of patients in group 1 may be interpreted as an indication of higher patient acuity in this group. However, it is thought that the lack of significant differences in other variables more specific for high patient acuity, such as total hospital days, total postoperative hospital days, total postoperative ICU days, total days of postoperative mechanical ventilation, and in-hospital mortality rates, more strongly supports the contention that the groups are comparable. The shorter preoperative hospitalization and preoperative ICU stay of group 2 patients is more likely the result of an increased demand for cost containment by decreasing resource utilization, ie, shorter hospital stays, in 1987.
The greater number of postoperative cardiac output determinations in group 2 may have been the result of continuous monitoring of SVOZ. Minute-to-minute changes in this value may have suggested to house staff physicians that changes in the patient's clinical status had occurred that warranted further investigation by cardiac output determination. No protocol existed in the ICU governing the response to changes in measured SVO,. Due to a paucity of written information in patient charts, it was not possible, in this retrospective study, to determine clear indications for ordering cardiac output determinations or what changes in therapy, if any, were based on either the change in SVO, or the cardiac output. During March and April of 1985, cardiac output determinations in the ICU required that the respiratory therapy department be summoned to perform these tests; whereas during the 1987 period, these determinations were performed by the nursing staff in the ICU. Therefore, the greater number of postoperative cardiac output determinations may simply be a reflection of greater availability. Another consideration may be that the reported lack of correlation between SV02 and cardiac output6y7 led the house staff to obtain a greater number of cardiac output determinations. Changes in SVOZ may be brought about by changes in cardiac output, hemoglobin concentration, oxygen delivery, and oxygen consumption.8 This requires that a change in 50, be evaluated to determine its etiology. Usually, this means obtaining the value of the cardiac output and other parameters of hemodynamic function.g Of interest is a similar increase in the number of cardiac output determinations reported by Pearson et al (personal communication, January 1988) in their study of the cost-effectiveness of Oximetrix pulmonary artery catheters in the treatment of patients following all types of open heart surgery. They attributed this increase in the number of cardiac output determinations in their study to possible overemphasis on the importance of monitored changes in SVO,.
It could be argued that the greater number of cardiac output determinations performed in group 2 reflected a superior level of care that was much more attuned to minute-to-minute variations in patient condition. Mitigating against this argument is the lack of difference in those parameters listed in Table 1 . A superior level of patient care would be expected to resdlt in shorter ICU and hospital stays, shorter periods of mechanical ventilation, fewer ABG determinations, and improved mortality in group 2. There is also no indication that the fewer number of preoperative hospital and KU days in group 2 were linked to the use of the fiberoptic pulmonary artery catheter. Forty-three out of 46, or 93.5%, of these catheters were placed as a routine measure immediately before surgery and were not used preoperatively in the ICU.
This study provides no evidence that the use of Oximetrix pulmonary artery catheters for the measurement of SS02 in the population studied has any cost-containment influence. In fact, the study suggests that the postoperative measurement of SV02 may increase the cost of care in this group by requiring more frequent cardiac output determinations during the postoperative period. The increased annual cost of routine use of Oximetrix pulmonary artery catheters in coronary artery bypass graft patients in the study institution is approximately $71,500 on a projected annual caseload of 550. The cost of the increased number of cardiac output determinations in the 1987 group cannot be calculated because their cost was included in the basic daily intensive care charge. This daily charge was $114 greater in the 1987 group, but no mechanism exists in the institution to separate the portion of this charge attributable to cardiac outputs. This study does not directly address the issue of increased quality of care given patients as a result of utilization of Oximetrix pulmonary artery catheters to constantly measure SV02. Indirect evidence that the quality of care in this group was not significantly improved is demonstrated by the lack of difference in postoperative hospital days, postoperative ABG determinations, days spent on mechanical ventilation postoperatively, and overall mortality. It would appear, based on the data, that the increased expense incurred by the use of Oximetrix pulmonary artery catheters for the continuous measurement of SV02 in patients undergoing elective coronary artery bypass grafting cannot be justified.
